Jurickson Profar is facing a 162-game suspension after testing positive for a performance-enhancing drug for the second time in roughly twelve months, according to ESPN. The ban, confirmed in early March 2026, strips the Atlanta Braves of their designated hitter for a full season. For a lineup already navigating offseason uncertainty, the timing cuts deep.
Profar’s case connects directly to the escalating penalty structures that govern NFL Suspensions and MLB drug bans alike. A first offense draws a shorter punishment. A second confirmed positive triggers a dramatically longer one. Profar now sits inside that second-offense tier, and the 162-game figure reflects exactly how severe those rules are built to be.
A Second Strike Under Drug Suspension Rules
Drug policies across major American sports share a common design: repeat violations carry heavier consequences. Profar’s 162-game ban flows directly from that framework. He survived one suspension, returned to a roster spot, and now faces erasure from an entire competitive calendar.
The Atlanta Braves absorbed a significant disruption from Profar during the previous season. This marks the second consecutive year the franchise scrambles around his absence. Front offices across baseball and football know this dynamic well. When a core contributor disappears for a full year, the ripple effects touch lineup construction, salary cap planning, and prospect development timelines at once. Atlanta’s front office must now identify a replacement who can absorb the at-bats and production Profar was projected to provide.
ESPN’s reporting confirmed Profar’s positive test through sources familiar with the league’s testing process. The specific substance has not been publicly identified, which is standard procedure at this stage of the appeals and notification process. That gap matters for salary cap implications tied to the contract. Teams generally cannot void deals on suspension grounds alone without specific contractual language.
A 162-game suspension removes a player from the active roster for an entire regular season. No service time accrues. No contribution to a team’s depth chart. For the Braves, the designated hitter slot must be filled through free agency, a trade, or an internal promotion. Three very different paths. Three very different cost structures.
Multiple reported alternatives have already surfaced in Atlanta’s orbit. The Braves have been linked to an Orioles Gold Glove finalist valued at approximately $6 million, described as seeking a fresh start after his time in Baltimore. Atlanta also reportedly lost a bidding contest to the Texas Rangers for a $1 million MVP and Gold Glove winner who had been targeted as a direct Profar replacement. The Rangers’ willingness to outbid Atlanta signals how quickly other clubs move when a roster hole of this size opens up.
A Gold Glove finalist at the $6 million range typically delivers strong defensive value alongside at least league-average offense. That profile fits what Atlanta needs if the front office wants to avoid a pure DH platoon. A player at that price point, arriving from a contending organization like Baltimore, brings playoff-caliber experience and a clear motivation to prove himself somewhere new.
NFL Suspensions and the Broader PED Ban Pattern
NFL Suspensions under the league’s PED policy follow a similar escalating structure to what Profar now faces in MLB. A first violation draws a four-game ban. A second confirmed positive results in a ten-game suspension. A third triggers a minimum one-year ban. Both the NFL’s framework and MLB’s 162-game second-offense penalty reflect a deliberate design choice by league commissioners and players’ unions: make the second violation costly enough that deterrence becomes structural.
Tracking this trend over three seasons, high-profile second-offense NFL Suspensions and MLB bans have grown more frequent. General managers in both sports now factor suspension risk into roster construction models, much the way they account for injury probability in long-term contract decisions. Some player advocates argue that escalating penalties disproportionately punish athletes who may have unknowingly ingested banned substances through contaminated supplements. That counterargument has gained traction in arbitration hearings across multiple leagues.
Atlanta’s back-to-back Profar disruptions offer a sharp lesson for front offices everywhere. Teams that build redundancy at premium offensive positions absorb these shocks far more cleanly than clubs that rely on a single player to anchor a lineup slot. The Braves have now lived that vulnerability twice in a row.
Profar’s ban triggers the maximum penalty tier under MLB’s joint drug agreement, covering a full 162-game regular season.
Atlanta reportedly lost a bidding contest to Texas for a $1 million MVP and Gold Glove winner targeted as a Profar replacement.
Multiple analysts project the Braves pursuing a $4 million Gold Glove finalist with 149 career home runs as a durable veteran fill.
A separate projection has Atlanta signing a $5 million former MVP and five-time All-Star with Gold Glove credentials to address the vacancy.
One trade scenario targets a $5 million World Baseball Classic champion with elite plate discipline as a replacement option.
Atlanta’s Next Move Before Opening Day
Atlanta’s front office faces a compressed timeline to address the DH vacancy before Opening Day. The Orioles’ Gold Glove finalist at $6 million represents the most prominently reported option, fitting within a reasonable range for a one-year stopgap or a longer bridge deal. Whether the Braves pull the trigger on a free agent, pursue a trade, or elevate an internal candidate depends heavily on remaining salary cap space and broader roster priorities heading into 2026.
The Braves’ situation carries a cautionary note for front offices across baseball and football. Roster construction in the modern era must account for the real possibility that a contracted player disappears for a full year due to a drug ban. Atlanta’s two-year experience with Profar is a case study in exactly that vulnerability.
Frequently Asked Questions
How does MLB’s 162-game suspension compare to NFL Suspensions for PED violations?
MLB’s second-offense PED ban covers 162 games, equivalent to a full regular season. Under NFL Suspensions policy, a second confirmed PED positive draws a ten-game ban, while a third offense triggers a minimum one-year suspension. MLB’s escalation is steeper at the second-offense level, reflecting differences in how each league’s collective bargaining agreement structures deterrence.
Does Profar retain his salary during the 162-game suspension?
Under MLB’s joint drug agreement, players serving PED suspensions forfeit their salary for the duration of the ban. Profar would not accrue service time during the suspension period, which affects both his earnings and his path to free agency eligibility depending on where he stands in his current contract cycle.
Can Profar appeal the 162-game ban?
MLB’s drug agreement allows players to appeal suspensions before an independent arbitrator. The appeal process can delay the start of the suspension while the case is reviewed. However, second-offense bans under the joint drug program carry a high bar for reversal, and most appeals at this penalty level result in the original suspension being upheld or only marginally reduced.
Which Atlanta Braves prospects could fill the DH role internally?
Atlanta’s farm system includes several corner outfield and first base prospects who profile as potential DH candidates. The organization has historically preferred to address vacancies of this scale through trades or free agency rather than accelerating a prospect’s timeline, particularly when the team views itself as a contender in the current window.
How have other MLB teams handled full-season suspensions in recent years?
Teams like the New York Yankees and San Diego Padres have navigated full-season absences by acquiring veteran stopgaps through mid-level free agent deals or waiver claims. The most successful responses combined a short-term external addition with an internal candidate receiving expanded playing time, spreading the production replacement across two roster spots rather than expecting one player to replicate the suspended player’s full output.
Jake Whitmore is a small-town Texas reporter who worked his way up from covering Friday night high school football to the NFL. With over nine years in sports journalism, Jake writes like he is talking to fans at a tailgate -- direct, passionate, and full of the enthusiasm that makes football Sundays special. He covers game previews, roster moves, and the fan perspective on every major NFL storyline.
